相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Measuring Clinical Importance in a Trial of Interventions for Mixed Urinary Incontinence
Toshi A. Furukawa
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis
Brooke Levis et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
One (effect) size does not fit at all: Interpreting clinical significance and effect sizes in depression treatment trials
Fredrik Hieronymus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Vanina Popova et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
Maggie Fedgchin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
Improving Depression Outcome by Patient-Centered Medical Management
A. John Rush et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review
Ahmad Ousmen et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2018)
Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression
Charles R. Conway et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Determination of a clinically important difference and definition of a responder threshold for the UCSD performance-based skills assessment (UPSA) in patients with major depressive disorder
Philip D. Harvey et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
What does the MADRS mean? Equipercentile linking with the CGI using a company database of mirtazapine studies
Stefan Leucht et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Evidence to Support Montgomery-Asberg Depression Rating Scale Administration Every 24 Hours to Assess Rapid Onset of Treatment Response
Kristen M. Johnson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Isn't It About Time to Employ Measurement-Based Card in Practice?
A. John Rush
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Narrowing the Gaps Between What We Know and What We Do in Psychiatry
A. John Rush
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions
Nathaniel P. Katz et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2015)
The structure of the Montgomery-Asberg depression rating scale over the course of treatment for depression
Lena C. Quilty et al.
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2013)
Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression
Ibrahim Turkoz et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Evaluating and Monitoring Treatment Response in Depression Using Measurement-Based Assessment and Rating Scales
Madhukar H. Trivedi
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Utility and limitations of PHQ-9 in a clinic specializing in psychiatric care
Takeshi Inoue et al.
BMC PSYCHIATRY (2012)
Enhancing the clinical utility of depression screening
Kurt Kroenke
CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)
Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale
Kathy Harnett Sheehan et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Report by the ACNP Task Force on response and remission in major depressive disorder
A. John Rush et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Monitoring depression treatment outcomes with the patient health questionnaire-9
B Löwe et al.
MEDICAL CARE (2004)
The Clinical Global Impression-Schizophrenia scale:: a simple instrument to measure the diversity of symptoms present in schizophrenia
JM Haro et al.
ACTA PSYCHIATRICA SCANDINAVICA (2003)
The PHQ-9 - Validity of a brief depression severity measure
K Kroenke et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2001)
分享论文
